| Literature DB >> 24965775 |
Can Luo1, Guobo Shen1, Ning Liu1, Fengming Gong1, Xiawei Wei2, Shaohua Yao1, Dan Liu3, Xiu Teng1, Ning Ye1, Nan Zhang1, Xikun Zhou1, Jiong Li1, Li Yang1, Xia Zhao5, Li Yang1, Rong Xiang6, Yu-Quan Wei2.
Abstract
Ammonia levels are often elevated in patients with cirrhosis or tumors. Patients with these diseases are immunocompromised. In this study, we investigated the effects of ammonia on a member of the immune cell family, the dendritic cells (DCs). Our results demonstrated that ammonia diminished cell count, phagocytosis, and lymphocyte stimulation of DCs. Ammonia also induced DC swelling, excessive reactive oxygen species production, and mitochondrial damage, which may constitute the underlying mechanism of ammonia-induced DC dysfunction. In ammonium chloride (NH4Cl)-loaded mice, DCs exhibited lowered phagocytosis and a weakened immune response to the chicken OVA vaccine. DCs from patients with cirrhosis or ammonia-treated healthy human blood both exhibited diminished phagocytosis. Moreover, tumor cell conditioned medium drove DCs into dysfunction, which could be reversed by ammonia elimination. In a murine colon carcinoma model, we found that ammonia could regulate tumor growth involving DCs and their related immune response. These findings reveal that ammonia could drive DCs into dysfunction, which contributes to the immunocompromised state of patients with cirrhosis or tumors.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24965775 DOI: 10.4049/jimmunol.1303218
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422